U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07672574) titled 'Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers' on June 12.
Brief Summary: This is an open, two-part study in healthy male volunteers, aged 30-65 years.
This trial aims to understand how the human body absorbs, distributes, metabolizes and eliminates ontunisertib after a single oral dose of radiolabelled test medicine ([14C]ontunisertib) and determine the routes and rates of elimination of the test medicine.
Study Start Date: July 20
Study Type: INTERVENTIONAL
Condition:
Fibrostenotic Crohn's Disease
Intervention:
DRUG: Ontunisertib
Oral capsule
DRUG: [14C]ontunisertib
IV infusion
DRUG: [14C]ontunise...